
Oncology NEWS International
- Oncology NEWS International Vol 11 No 2
- Volume 11
- Issue 2
Study Estimates Worldwide Prevalence of 25 Adult Cancers
LYON, France-A study from the International Agency for Research on Cancer (IARC) shows a higher cancer prevalence in the developed world, primarily because of longer life expectancy in richer countries (Int J Cancer 97:72-81, 2002).
LYON, FranceA study from the International Agency for Research on Cancer (IARC) shows a higher cancer prevalence in the developed world, primarily because of longer life expectancy in richer countries (Int J Cancer 97:72-81, 2002).
The study examined the prevalence of 25 adult cancers for 11 world areas using data from IARC for developing countries, US SEER, and EUROCARE I. The study described the number of cancer cases diagnosed between 1986 and 1990 among individuals aged 15 or older who were still alive at the end of 1990.
Lead author Paola Pisani, reported the highest cancer prevalence in North America at 1.5%. Western Europe and Australia/New Zealand had a prevalence of 1.2% and 1.1%, respectively, followed by Japan at 1%, Eastern Europe at 0.7%, and Latin American and the Caribbean at 0.4%. The lowest prevalence (0.2%) was found in sub-Saharan Africa, the Middle East and Northern Africa, and Southeastern and South Central Asia.
Articles in this issue
over 24 years ago
R115777 Has Significant Activity in CML and Myelofibrosisover 24 years ago
National Cancer Prevention Campaign Discussedover 24 years ago
CHOP Plus Rituxan Proves Cost-Effective in B-Cell Lymphomaover 24 years ago
Lung Cancer Screening Protocol Moves Forwardover 24 years ago
Cancer Prevention Research Hampered by Lack of Biomarkersover 24 years ago
Rituximab Improves Efficacy of Chemotherapy for Follicular Lymphomasover 24 years ago
Long Survival Confirmed in CML Patients Who Respond to InterferonRelated Content




109 Extended Adjuvant Neratinib in HER2+/HR+ Early Breast Cancer in Clinical Routine: Final Results from the Multi-national, Prospective, Observational Study ELEANOR



















































